These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16441428)
1. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey. Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly]. Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246 [TBL] [Abstract][Full Text] [Related]
4. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma. Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141 [TBL] [Abstract][Full Text] [Related]
5. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly. Wang E; Papavassiliou P; Sebastian S Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report. Yu M; Zhang Q; Xu S; Yin T; Li F Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604 [TBL] [Abstract][Full Text] [Related]
7. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Nicolae A; Pittaluga S; Abdullah S; Steinberg SM; Pham TA; Davies-Hill T; Xi L; Raffeld M; Jaffe ES Blood; 2015 Aug; 126(7):863-72. PubMed ID: 25999451 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection in Richter's transformation. Ansell SM; Li CY; Lloyd RV; Phyliky RL Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100 [TBL] [Abstract][Full Text] [Related]
9. Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma. Law MF; Poon WL; Ng KS; Chan HN; Lai HK; Ha CY; Ng C; Yeung YM; Yip SF Ann Hematol; 2012 May; 91(5):789-791. PubMed ID: 21881823 [No Abstract] [Full Text] [Related]
10. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis. Song CG; Huang JJ; Li YJ; Xia Y; Wang Y; Bi XW; Jiang WQ; Huang HQ; Lin TY; Li ZM PLoS One; 2015; 10(7):e0133973. PubMed ID: 26222726 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy. Ahn JS; Yang DH; Duk Choi Y; Jung SH; Yhim HY; Kwak JY; Sung Park H; Shin MG; Kim YK; Kim HJ; Lee JJ Am J Hematol; 2013 Sep; 88(9):774-9. PubMed ID: 23760676 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era. Sato A; Nakamura N; Kojima M; Ohmachi K; Carreras J; Kikuti YY; Numata H; Ohgiya D; Tazume K; Amaki J; Moriuchi M; Miyamoto M; Aoyama Y; Kawai H; Ichiki A; Hara R; Kawada H; Ogawa Y; Ando K Cancer Sci; 2014 Sep; 105(9):1170-5. PubMed ID: 24974976 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
14. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Yang QX; Pei XJ; Tian XY; Li Y; Li Z Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632 [TBL] [Abstract][Full Text] [Related]
15. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case]. Li WS; Xie JL; Zhang M; Zhou XG Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):128-9. PubMed ID: 23710923 [No Abstract] [Full Text] [Related]
16. Epstein-Barr virus-induced transformation of cutaneous plasmacytoma into CD30+ diffuse large B-cell lymphoma. Donner LR Am J Dermatopathol; 2004 Feb; 26(1):63-6. PubMed ID: 14726824 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265 [TBL] [Abstract][Full Text] [Related]
19. Reappraisal of Primary Epstein-Barr Virus (EBV)-positive Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract: Comparative Analysis Among Immunosuppressed and Nonimmunosuppressed Stage I and II-IV Patients. Miyagi S; Ishikawa E; Nakamura M; Shimada K; Yamamura T; Furukawa K; Tanaka T; Mabuchi S; Tsuyuki Y; Kohno K; Sakakibara A; Satou A; Kato S; Fujishiro M; Nakamura S Am J Surg Pathol; 2020 Sep; 44(9):1173-1183. PubMed ID: 32349049 [TBL] [Abstract][Full Text] [Related]
20. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review. Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]